コメント (10)
トラックバックは利用できません。
The “trailing effect” in vitro can make susceptibility interpretation for Candida challenging.
Diflucan penetration into the CSF is excellent, a key pharmacological advantage.
Activity is pH-dependent, with optimal efficacy in neutral to slightly acidic environments.
“Fluconazole-refractory” candidiasis is a specific clinical entity in advanced AIDS.
Diflucan is not first-line for invasive aspergillosis under any circumstances.
Resistance to Diflucan is a growing concern, particularly with Candida glabrata and krusei.
Rifampin induces fluconazole metabolism, potentially leading to subtherapeutic levels.
Diflucan is a model of predictable pharmacokinetics within the azole class.
Therapeutic drug monitoring for Diflucan is not routine but can guide therapy in complex cases.
The “trailing effect” in vitro can make susceptibility interpretation for Candida challenging.
Diflucan penetration into the CSF is excellent, a key pharmacological advantage.
Activity is pH-dependent, with optimal efficacy in neutral to slightly acidic environments.
“Fluconazole-refractory” candidiasis is a specific clinical entity in advanced AIDS.
Diflucan is not first-line for invasive aspergillosis under any circumstances.
Resistance to Diflucan is a growing concern, particularly with Candida glabrata and krusei.
Rifampin induces fluconazole metabolism, potentially leading to subtherapeutic levels.
Diflucan is a model of predictable pharmacokinetics within the azole class.
Therapeutic drug monitoring for Diflucan is not routine but can guide therapy in complex cases.
Resistance to Diflucan is a growing concern, particularly with Candida glabrata and krusei.